Stay updated on IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page
- Check6 days agoChange DetectedThe page’s displayed interface/version label has been updated from Revision v3.5.2 to Revision v3.5.3, indicating a platform UI release rather than a change to the underlying trial record.SummaryDifference0.1%

- Check14 days agoChange DetectedA new Revision: v3.5.2 was added to the history, replacing the previous Revision: v3.5.0.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check43 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 deleted in the Record History. This update appears to reflect site maintenance rather than changes to the study data or record details.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 in the history section.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.4.2 was added to the history and Revision: v3.4.1 was removed, reflecting UI/version updates.SummaryDifference0.6%

- Check85 days agoChange DetectedAdded a site-wide funding notice and a new revision tag (v3.4.1) while removing the previous revision tag (v3.4.0).SummaryDifference0.7%

Stay in the know with updates to IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page.